- Clever Leaves (NASDAQ:CLVR) expands partnership with Cantourage to include supply of Clever Leaves’ second pharmaceutical-grade cannabis product, cultivated in the company’s Portugal facilities, to the German medicinal cannabis market.
- Cantourage will utilize Clever Leaves’ product to produce IQANNA 10 which will have one of the highest THC levels available in German pharmacies.
- Clever Leaves and Cantourage’s expanded partnership further increases the range of international, high-quality medical cannabis products available to the EU market under Clever Leaves’ brand IQANNA and further strengthen the Company as a multinational operator.
Recommended For You
More Trending News
See More »